Nutralife Biosciences Stock Net Income
Nutralife Biosciences fundamentals help investors to digest information that contributes to Nutralife Biosciences' financial success or failures. It also enables traders to predict the movement of Nutralife Pink Sheet. The fundamental analysis module provides a way to measure Nutralife Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutralife Biosciences pink sheet.
Nutralife |
Nutralife Biosciences Company Net Income Analysis
Nutralife Biosciences' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Nutralife Biosciences Net Income | (5.83 M) |
Most of Nutralife Biosciences' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutralife Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Nutralife Biosciences reported net income of (5.83 Million). This is 101.71% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 101.02% higher than that of the company.
Nutralife Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutralife Biosciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutralife Biosciences could also be used in its relative valuation, which is a method of valuing Nutralife Biosciences by comparing valuation metrics of similar companies.Nutralife Biosciences is currently under evaluation in net income category among its peers.
Nutralife Fundamentals
| Return On Equity | -14.26 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (3.80) % | |||
| Current Valuation | 11.61 M | |||
| Shares Outstanding | 176.62 M | |||
| Shares Owned By Insiders | 45.95 % | |||
| Price To Book | 85.51 X | |||
| Price To Sales | 14.09 X | |||
| Revenue | 626.62 K | |||
| Gross Profit | 83.59 K | |||
| EBITDA | (5.71 M) | |||
| Net Income | (5.83 M) | |||
| Cash And Equivalents | 51.8 K | |||
| Total Debt | 10 K | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (487.39 K) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 12 | |||
| Beta | -0.9 | |||
| Market Capitalization | 6.62 M | |||
| Total Asset | 4.85 M | |||
| Net Asset | 4.85 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |